Related Experiment Video
Updated: Jun 14, 2026

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)
Published on: September 13, 2018
Respiratory Depression in Young Prader Willi Syndrome Patients following Clonidine Provocation for Growth Hormone
Gregory A Hollman1, David B Allen, Jens C Eickhoff
1American Family Children's Hospital, Department of Pediatrics, University of Wisconsin, Madison, WI 53792, USA.
Insights
Clonidine used for growth hormone (GH) testing in children with Prader Willi Syndrome (PWS) caused significant sedation and respiratory depression. Doses often exceeded those for sedation, leading to concerning effects in some patients.
Area of Science:
- Pediatric Endocrinology
- Pharmacology
- Genetics
Background:
- Prader Willi Syndrome (PWS) is a complex genetic disorder affecting multiple body systems.
- Growth hormone (GH) deficiency is common in PWS, necessitating accurate assessment.
- Clonidine is sometimes used to stimulate GH secretion, but its safety profile in PWS requires evaluation.
Purpose of the Study:
- To assess the sedative and respiratory effects of clonidine when administered for growth hormone (GH) secretion evaluation in children with Prader Willi Syndrome (PWS).
Main Methods:
- A prospective study involving 17 children with PWS, undergoing up to four clonidine challenge tests over three years.
- Clonidine was administered at a dose of 0.15 mg/m(2).
- Vital signs, oxygen saturation, and sedation levels were meticulously recorded at baseline and every five minutes post-administration.
Main Results:
- All 60 studies resulted in sedation scores of 4-5 (drowsy to asleep).
- Significant mean declines in respiratory rate (7.5 breaths/min) and oxygen saturation (2.2%) were observed (P < .001).
- Nine instances of oxygen saturation ≤94% occurred in five patients (29%), with three linked to partial airway obstruction.
Conclusions:
- Clonidine doses used for GH assessment in PWS frequently surpass typical sedation doses.
- These higher doses can lead to considerable respiratory depression and oxygen desaturation in some children with PWS.
- No correlation was found between oxygen desaturation and Body Mass Index (BMI) in this cohort.
Abstract:
Objectives. To determine the sedative and respiratory effects of clonidine when used to evaluate growth hormone (GH) secretion in children with Prader Willi Syndrome (PWS). Methods. The study prospectively evaluated children with PWS who received clonidine (0.15 mg/m(2)) to assess GH responsiveness. Patients were studied up to four times over three years. Vital signs, oxygen saturation, and sedation level were recorded at baseline and every five minutes following clonidine. Changes between baseline and post-clonidine were evaluated using a repeated measurement analysis. Results. Sixty studies were performed on 17 patients, mean age 30.4 +/- 15.0 months. The mean +/- SD dose of clonidine was 0.074 +/- 0.027 mg (5.3 +/- 1.72 mcg/kg). All patients achieved a sedation score of 4 to 5 (drowsy to asleep). Mean declines in respiratory rate (7.5 +/- 6.1 breaths/min; P < .001), and oxygen saturation (2.2 +/- 2.0%; P < .001) occurred following clonidine. Five patients (29%) experienced oxygen saturations =94% on nine occasions. Three oxygen desaturations were accompanied by partial airway obstruction. Conclusions. Clonidine doses to assess GH secretion often exceed doses used for sedation and result in significant respiratory depression in some children with PWS. There was no association between oxygen desaturation and BMI.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Cushing Syndrome II: Pathophysiology
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Acute Respiratory Failure-IV
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
